ESR1 and Parkinson disease: In different neurotoxin animal models of PD, protective effects have been obtained when treating the animals with estrogens, as well as ER modulators (SERMs) or ER agonists (reviewed in [187]), thus suggesting that a potential repositioning of steroids, particularly estrogens, may improve the life quality of PD patients [186].